Long-term Study in Patients With Chronic Kidney Disease and Hyperphosphatemia on Hemodialysis
A Phase 3, Long-term Study in Patients With Chronic Kidney Disease (CKD) and Hyperphosphatemia on Hemodialysis
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Phase 3
Contacts and Locations
Study Locations
-
-
-
Chubu, Japan
-
Chugoku, Japan
-
Kansai, Japan
-
Kantou, Japan
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Chronic kidney disease patients on hemodialysis
- Hyperphosphatemia
- Written informed consent
Exclusion Criteria:
- Patients with gastrointestinal surgery or enterectomy
- Severe cardiac disease patients
- Patients with severe constipation or diarrhea
- Patients with a complication of malignant tumors
- Patients with uncontrolled hypertension
- Patients treated with parathyroid intervention
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: 1. ASP1585
|
oral
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Changes in serum Phosphorus level
Time Frame: After 48 weeks
|
After 48 weeks
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Percent of the patients meeting the target range of serum Phosphorus levels
Time Frame: During the treatment
|
During the treatment
|
|
Changes in serum Calcium level
Time Frame: After 48 weeks
|
After 48 weeks
|
|
Changes in serum Ca x P
Time Frame: After 48 weeks
|
After 48 weeks
|
|
Changes in intact PTH level
Time Frame: After 48 weeks
|
After 48 weeks
|
Collaborators and Investigators
Sponsor
Sponsor
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Estimate)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 1585-CL-0004
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.